Stocktoria
TELEFLEX INC TFX
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1980-03-17
TELEFLEX INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.0B | $1.7B | $1.7B | $2.8B | $2.8B |
| Gross profit | $1.1B | $1.0B | $1.0B | $1.5B | $1.5B |
| R&D expense | $144.8M | $109.0M | $113.6M | $153.8M | $130.8M |
| SG&A expense | $720.2M | $674.5M | $622.7M | $863.7M | $860.1M |
| Operating income | $118.4M | $103.7M | $258.7M | $499.7M | $628.1M |
| Interest expense | — | — | $85.1M | $54.3M | $57.0M |
| Income tax | -$34.0M | -$30.9M | $41.9M | $83.0M | $74.3M |
| Net income | -$905.6M | $69.7M | $356.3M | $363.1M | $485.4M |
| EPS (diluted) | $-20.25 | $1.48 | $7.53 | $7.68 | $10.23 |
| Operating cash flow | $96.7M | $301.9M | $206.1M | $342.8M | $652.1M |
| Free cash flow | $1.4M | $211.4M | $159.7M | $263.6M | $580.5M |
| Cash & equivalents | $378.6M | $247.9M | $222.8M | $292.0M | $445.1M |
| Inventory | $404.4M | $306.8M | $626.2M | $578.5M | $477.6M |
| Total assets | $6.9B | $7.1B | $7.5B | $6.9B | $6.9B |
| Total liabilities | $3.8B | $2.8B | $3.1B | $2.9B | $3.1B |
| Shareholders' equity | $3.1B | $4.3B | $4.4B | $4.0B | $3.8B |
Source: SEC EDGAR filings · CIK 0000096943 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.